Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01858285 · ClinicalTrials.gov registry record

Genetics of Epilepsy and Related Disorders

A clinical trial of Epilepsy and Epileptic Encephalopathy, sponsored by Boston Children's Hospital.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT01858285: Recruiting study of Epilepsy and Epileptic Encephalopathy, sponsored by Boston Children's Hospital.

NCT01858285 is a study of Epilepsy and Epileptic Encephalopathy that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 5,000 participants, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01858285, a study of Epilepsy and Epileptic Encephalopathy, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to epilepsy and related disorders. These findings may help explain the broad spectrum of clinical characteristics and outcomes seen in people with epilepsy.

Primary Outcome

Use exome and/or whole genome sequencing to identify genetic variants. Detailed clinical information will be collected via medical records and patient questionnaire, as well as biological parents' exome sequencing to classify variants per ACMG guidelines.

Interventions

  • GENETIC Exome and/or whole genome sequencing

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2010-11
Est. Completion 2030-12
Boston Children's Hospital

462 total trials

What NCT01858285 shows while recruiting

NCT01858285 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher).

The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Exome and/or whole genome sequencing is the first listed.

NCT01858285 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01858285 about?

NCT01858285 is a clinical study titled "Genetics of Epilepsy and Related Disorders". Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to epilepsy and related disorders. These findings may help explain the broad spectrum of clinical characteristics and outcomes seen in people with epilepsy.

What is the current status of trial NCT01858285?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2010-11. Estimated completion is 2030-12.

What conditions does trial NCT01858285 study?

This clinical trial studies the following conditions: Epilepsy, Epileptic Encephalopathy.

What interventions are being tested in trial NCT01858285?

The interventions under investigation include: Exome and/or whole genome sequencing (GENETIC).

Who is sponsoring clinical trial NCT01858285?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01858285 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01858285's enrollment target sits among peer trials

5,000 3rd of 160 higher than 157 of 160 other Epilepsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

  • NCT00991094 · 5,000 participants

    Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01858285, the US trial registry maintained by the National Library of Medicine. NCT01858285 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.